Pricing Log in Create free account

ADARx Pharmaceuticals, Inc. (ADRX) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

ADARx Pharmaceuticals, Inc. and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.5B and $1.5B).

Valuation

Metric ADRX IMCR Biotechnology median
P/E — n/m 10.60
P/S — 3.71 9.40
P/B — 3.80 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 2.64 9.02
Earnings yield — (2.06%) (32.88%)
Free cash flow yield — (1.14%) (23.13%)

Profitability

Metric ADRX IMCR Biotechnology median
Gross margin — 98.86% 68.51%
Operating margin — (6.76%) 0.00%
Net margin — (7.48%) 0.00%
Free cash flow margin — (4.24%) 0.00%
Return on equity — (7.87%) (51.96%)
Return on assets — (2.88%) (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric ADRX IMCR Biotechnology median
Revenue growth (TTM) — 13.10% 6.76%
EPS growth (last fiscal year) — 30.39% 29.88%
Revenue growth, 5-year CAGR — 59.57% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADRX IMCR Biotechnology median
Debt to equity — 0.94 0.00
Current ratio — 4.62 4.97
Net debt to EBITDA — 11.19 1.01

Dividend

Metric ADRX IMCR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADRX IMCR Biotechnology median
Market cap 1.47b 1.46b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack